From Bench to Fireside™ is a podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients.
From Bench to Fireside
Claim This Podcastby Parker Institute for Cancer Immunotherapy
5.0(14 reviews)
15 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
13
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality14
Social0
YouTube0
Engagement32
Podcast Overview
From Bench to Fireside™ is a podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients.
Language
🇺🇲
Publishing Since
1/24/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
13
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality14
Social0
YouTube0
Engagement32
4
Excellent Areas
2
Good Performance
13
Growth Opportunities
excellent
Episode Length
42 minutes
Performing excellently!
good
Website Presence
1 link(s)
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 30 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind From Bench to Fireside
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
April 17, 2025
From Biological Limits to Intelligent Immunity with Kole Roybal, PhD
<p>What if our immune cells could be reprogrammed to sense, decide and act—outsmarting even the most elusive tumors?</p><p>In this episode of From Bench to Fireside Kole Roybal, PhD, Director of the Parker Institute of Cancer Immunotherapy Center at UCSF, joins PICI Chief Scientific Officer John Connolly, PhD, to break down how engineered immune cells are moving from the lab to the clinic—and changing how we approach solid tumors. They discuss how technologies like SynNotch and SNIPR are giving immune cells programmable intelligence—and how PICI’s collaborative model helped accelerate these innovations from discovery to patient-ready therapies.</p><p>Along the way, Dr. Roybal reflects on mentorship, team-building and how engineered immunity could reshape medicine far beyond cancer.</p><p></p><p>—</p><p></p><p>From Bench to Fireside™ is a podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients. Along the way, they unpack the hurdles encountered and the opportunities that lie ahead.</p><p>Tune in to hear from scientific leaders who stand at the forefront of developing breakthrough immune therapies with the goal of turning all cancers into curable diseases. From Bench to Fireside™ is produced by the Parker Institute for Cancer Immunotherapy. Follow PICI on <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.linkedin.com/company/parker-institute-for-cancer-immunotherapy/">LinkedIn</a>, X <a target="_blank" rel="noopener noreferrer nofollow" href="https://twitter.com/parkerici">@parkerici</a> or visit <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.parkerici.org">www.parkerici.org</a>.</p>
March 10, 2025
From Cancer’s Hidden Metabolic Tricks to Breakthrough Discoveries That Overcome Them with Roberta Zappasodi, PhD
<p>In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Roberta Zappasodi, PhD, Assistant Professor of Hematology and Medical Oncology and member of the PICI Center at Weill Cornell Medicine.</p><p>Dr. Zappasodi has been instrumental in uncovering immunotherapy resistance -- from her early career preparing vaccines from tumor samples, to her current, cutting-edge research on how tumor environments impact treatment. Together, they explore her discoveries on the relationship between tumor glycolytic states and vasculature, the importance of T-cell trafficking, and the transformative potential of combining therapies.</p><p>They also discuss the importance of moving immunotherapies to earlier treatment stages, PICI's role in fostering collaborative research, mentoring the next generation of researchers, her upcoming research on tumor metabolism... and more!</p><p>--</p><p>From Bench to Fireside™ is a new podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients. Along the way, they unpack the hurdles encountered and the opportunities that lie ahead.</p><p>Tune in to hear from scientific leaders who stand at the forefront of developing breakthrough immune therapies with the goal of turning all cancers into curable diseases. From Bench to Fireside™ is produced by the Parker Institute for Cancer Immunotherapy. Follow PICI on <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.linkedin.com/company/parker-institute-for-cancer-immunotherapy/">LinkedIn</a>, X <a target="_blank" rel="noopener noreferrer nofollow" href="https://twitter.com/parkerici">@parkerici</a> or visit <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.parkerici.org">www.parkerici.org</a>.</p>
February 24, 2025
From Metastatic Melanoma to Immune Engineering with Antoni Ribas, MD, PhD
<p>In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Antoni Ribas, MD, PhD, Director of the PICI Center at UCLA, professor of medicine at the David Geffen School of Medicine at UCLA and Director of the Tumor Immunology Program at the UCLA Health Jonsson Comprehensive Cancer Center.</p><p>Dr. Ribas, who led one of the largest phase 1 clinical oncology trial to date, has been instrumental in advancing our understanding of immune checkpoint inhibitors and cellular therapies. Together, they explore Dr. Ribas' journey from his early work in immunology to his current cutting-edge research in reprogramming immune system cells, discussing overarching trends in patient outcomes and the transformative potential of multiplex trials. They also discuss PICI's collaborative approach to uniting scientists, investors and cell therapies together, Dr. Ribas's perspective on prioritizing scientific advancement over publication, his vision of shifting cancer from a surgical disease to an immunotherapy-treatable condition, his insights on mentoring the next generation of researchers… and more.</p><p>--</p><p>From Bench to Fireside™ is a new podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients. Along the way, they unpack the hurdles encountered and the opportunities that lie ahead.</p><p>Tune in to hear from scientific leaders who stand at the forefront of developing breakthrough immune therapies with the goal of turning all cancers into curable diseases. From Bench to Fireside™ is produced by the Parker Institute for Cancer Immunotherapy. Follow PICI on <a target="_blank" rel="noopener nofollow" href="https://www.linkedin.com/company/parker-institute-for-cancer-immunotherapy/">LinkedIn</a>, X <a target="_blank" rel="noopener nofollow" href="https://twitter.com/parkerici">@parkerici</a> or visit <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.parkerici.org">www.parkerici.org</a>.</p>
15 total episodes available
Deep-dive analytics for From Bench to Fireside
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is From Bench to Fireside?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.